Skip to main content

Together we are beating cancer

Donate now

Clinical trials

Showing 12 out of 311 results
Surgeons in theatre

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer. The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

by Cancer Research UK | News | 3 June 2018

3 June 2018

A chemotherapy line going into a patient's arm

A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy. A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.

by Cancer Research UK | News | 3 June 2018

3 June 2018

Nurse giving cancer treatment

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results. Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

by Cancer Research UK | News | 16 May 2018

16 May 2018

This entry is part 7 of 23 in the series Science Surgery
Lab test

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results. A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.

by Cancer Research UK | News | 22 February 2018

22 February 2018

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK. Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK.

by Cancer Research UK | News | 15 February 2018

15 February 2018

Doctor discussing a prostate scan with a patient

An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results.

by Cancer Research UK | News | 9 February 2018

9 February 2018

  • Science & Technology
  • Health & Medicine

2017 cancer research highlights: a patient's pick

Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him. Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him.

by Gabriella Beer | Analysis | 20 December 2017

20 December 2017

Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results. Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results.

by Cancer Research UK | News | 8 December 2017

8 December 2017

This entry is part 29 of 30 in the series Our milestones